1.
Yıldırım S, Alan Özkan, Türkoğlu E, Sariyar Busery N, Doğan A, Akdağ G, et al. Impact of Blood Type on Treatment Response and Survival in HER2-Negative Metastatic Gastric Cancer. Cerrahpaşa Medical Journal [Internet]. 2025 Oct. 19 [cited 2025 Dec. 17];49(1):1-6. Available from: https://cerrahpasamedj.org/index.php/pub/article/view/966